DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Zhou Y, Lin Z, Zhang X, Chen C, Zhao H, Hong S. et al.
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: Pembrolizumab or pembrolizumab plus chemotherapy.
J Immunother Cancer 2019;
7: 120
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.